Here we show that AT1R blockade using a pharmacological approach and AT1R deficiency by gene deletion attenuates atherosclerosis and improves endothelial function in diabetic and non-diabetic ApoE−/−-mice. The gene discussed is APOE; the disease is atherosclerosis.